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Storage of prescription veterinary 
medicines on UK dairy farms: a cross-
sectional study
Gwen M Rees,1 David C Barrett,1 Henry Buller,2 Harriet L Mills,1,3 Kristen K Reyher1
Prescription veterinary medicine (PVM) use in the UK is an area of increasing focus for the veterinary profession. 
While many studies measure antimicrobial use on dairy farms, none report the quantity of antimicrobials stored 
on farms, nor the ways in which they are stored. The majority of PVM treatments occur in the absence of the 
prescribing veterinarian, yet there is an identifiable knowledge gap surrounding PVM use and farmer decision 
making. To provide an evidence base for future work on PVM use, data were collected from 27 dairy farms in 
England and Wales in Autumn 2016. The number of different PVMs stored on farms ranged from 9 to 35, with 
antimicrobials being the most common therapeutic group stored. Injectable antimicrobials comprised the 
greatest weight of active ingredient found, while intramammary antimicrobials were the most frequent unit of 
medicine stored. Antimicrobials classed by the European Medicines Agency as critically important to human 
health were present on most farms, and the presence of expired medicines and medicines not licensed for use in 
dairy cattle was also common. The medicine resources available to farmers are likely to influence their treatment 
decisions; therefore, evidence of the PVM stored on farms can help inform understanding of medicine use.
Introduction
Prescription veterinary medicine (PVM) use in the 
UK is an area of increasing focus for the veterinary 
profession, agricultural sector, government and food 
retailers.1 The agricultural sector is a significant user of 
antimicrobials,2 and reducing its overall use along with 
improving data collection were key recommendations of 
the O’Neill report.3 According to the list published by the 
Veterinary Medicines Directorate in the UK, as of January 
1, 2018, there are 1876 prescription-only veterinary 
medicines (POM-V), of which 142 are licensed to treat 
solely cattle and 456 are licensed to treat multiple 
species including cattle. These comprise 152 different 
listed active ingredients.4 There are 233 different 
antimicrobial preparations (containing 60 listed active 
ingredients) licensed for use in cattle, with 75 licensed 
POM-V classed by the European Medicines Agency as 
highest priority, critically important antimicrobials 
(HP-CIA) to human health.5 Antimicrobial resistance is 
a recognised global threat, and there have been many 
calls for improved understanding of antimicrobial 
prescription, use and recording.1 3 6–8 Currently in the 
UK, antimicrobial use (AMU) in the dairy industry is 
measured through a combination of pharmaceutical 
production/import data and more recently using a 
sample of individual veterinary practice sales data. This 
has improved data granularity but may not represent 
actual use on farms.2 Data for other PVMs such as 
vaccines, NSAIDs or mechanical teat sealants are not 
currently measured or published nationally.
Farmers in the UK can purchase and store PVM on 
farm for use at a later date.9 Many studies measure 
AMU on dairy farms7 10–15; however, few/none report the 
quantity of antimicrobials stored on farms directly nor 
the way in which they are stored. Medicine storage on 
farms is an important part of compliance with Health 
and Safety Executive and farm assurance guidelines,16 17 
which require PVM to be placed in a secure, lockable 
location away from children, animals and thieves.18 In 
addition, medicines should be stored at the temperature 
requirements stated on the packaging. Despite this, a 
recent study found that vaccines were routinely being 
stored at inappropriate temperatures on UK farms.19 
There is currently little evidence available to determine 
whether PVMs are used in the way the prescribing 
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veterinarian intended, or whether farmers are making 
decisions based on other factors while using stored 
PVM which may be expired or not licensed for use in 
dairy cattle.
There is evidence in human health research that 
prescription medicines are often stored in the home 
for use at a later date, despite the prescription having 
been intended for immediate use.20 21 Studies have 
found that a proportion of patients deliberately 
planned to stop taking a course of prescribed 
antibiotics early in order to have a supply for self-use 
in the future.22 23 Non-compliant use of medicines 
is commonly seen,24 and there is evidence that 
medicines are taken in ways other than that indicated 
by the prescriber.25 26 It follows therefore that there 
is an urgent need for research into PVM storage and 
compliance in agriculture.
The aims of this study were to provide data on the 
storage practices of PVM on UK dairy farms and to 
investigate the quantity and composition of PVM being 
stored.
Materials and methods
Study design and population
This article was written according to the Strengthening 
the Reporting of Observational Studies in Epidemiology 
statement for scientific reporting of cross-sectional 
studies.27
Data in this study formed part of a wider project 
investigating PVM use on UK dairy farms. Twenty-
seven dairy farms in South West England and South 
Wales were enrolled. Veterinary practices within the 
study area were asked to recruit dairy farms. Mixed-
species farms were only included where PVM purchase 
and storage for the dairy herd were kept separate from 
other PVM. Selection of farms was purposive based on 
varying herd size, production levels and management 
practices. Veterinary practices were asked to nominate 
farms across the spectrum of perceived medicine storage 
compliance to minimise selection bias. All farms were 
visited once by the lead author in a six-week period in 
Autumn 2016.
On the day of the visit, a structured interview was 
conducted with the self-identified ‘main treatment 
decision-maker’ (hereafter called the farmer) to gather 
information on farm demographics, management 
practices, animal health and productivity. Stock 
numbers, production, health and fertility data were 
ascertained to the best of the farmer’s knowledge aided 
by consultation with on-farm records. For the PVM 
inventory the farmer was asked to indicate areas on 
the farm where PVM might be found. The designated 
medicine cupboard was examined first, and certain 
high-probability storage areas were directly inquired 
about (eg, household refrigerator, calf shed, milking 
parlour). Permission was also requested to search 
for PVM anywhere on the farm. A photograph of the 
medicine cupboard was taken and field notes written as 
an aide-memoire about the storage systems.
All PVMs found were entered on-location into a 
preprepared spreadsheet. Location, drug name, pack 
size, number of packs, quantity remaining in each pack 
and expiry dates were noted. Where the product label 
was illegible, it was disregarded. Where the expiry date 
was illegible, it was assumed to be within date. Volume 
remaining was estimated by eye to the nearest 10 per 
cent of pack size (ie, for a 100-ml pack of liquid, volume 
was estimated to the nearest 10 ml; and for a 50-g pack 
of powder, quantity was estimated to the nearest 5 g). 
All POM-V medicines were recorded along with any 
vaccines licensed for use in cattle and all pour-on, oral 
and injectable endectocides (anthelmintics). Vaccines 
were recorded in number of doses rather than volume. 
All intramammary and ocular medicines were recorded 
as single units per tube because one tube is equivalent 
to one dose.
Data analysis
All data were entered into separate spreadsheets, one 
per study farm. The data from these spreadsheets were 
Table 1 Demographic and management characteristics of the 27 
participating farms
Characteristics Response Farms (n)
Age of farmer (years) 18–30 5
31–40 5
41–50 5
>50 12
Education level of farmer Basic schooling 3
O level/GCSE/A level 4
HNC/HND/NVQ 16
University bachelor’s degree 4
Total herd size 100–199 6
200–299 12
300–699 10
>700 5
Total number of cows in 
milk
1-99 5
100–199 11
200–299 4
>300 7
Calving pattern Year-round 22
Seasonal—Spring 4
Seasonal—Autumn 1
Primary cow type Holstein 16
British Friesian 4
Channel Island 3
Crossbreed 2
Other 2
Waste milk feeding Yes—all calves 13
Yes—beef calves only 7
No 7
Dry cow antimicrobial 
therapy
Blanket therapy 18
Selective therapy 9
Basic schooling: no qualifications gained; blanket therapy: all dry cows treated with intramammary 
antimicrobial; farmer: self-described main treatment decision maker; selective therapy: certain dry 
cows not treated with intramammary antimicrobial based on somatic cell count and mastitis risk 
assessment.
GCSE, General Certificate of Secondary Education; HNC, Higher National Certificate; HND, Higher 
National Diploma; NVQ, National Vocational Certificate.
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then collated and analysed by retrieving specific data 
sets through the R software28 and producing a database 
for all 27 farms to be compared and analysed together.
Medicine quantities were measured in total milligram 
of active ingredient present, in milligram per population 
corrected unit (PCU) in line with nationally reported 
use data,29 and in the total number of ‘medicine units’ 
present. Medicine units were defined as one bottle of 
liquid, one tube of intramammary or ocular suspension, 
one pack of boluses or tablets, one container of powder, 
or one tube of ointment. PVMs were grouped according 
to therapeutic group (eg, antimicrobial, vaccine). 
Antimicrobials were grouped by antimicrobial class (eg, 
penicillin, fluoroquinolone) and according to route of 
administration (eg, injectable, intramammary). Expired 
medicines were defined as those medicines with an 
expiry date before the day of the inventory. Milligrams of 
active ingredient were presented to the nearest 100 mg 
for the total weight of active ingredient, to the nearest 
10 mg for milligram per cow in milk and milligram 
per 1000 litres of milk produced annually, and to the 
nearest 0.01 mg for mg/PCU.
Data were visually checked for normality. Normally 
distributed data were reported as a mean with sd in 
brackets. Non-normally distributed data were reported 
as a median with range in brackets. Calculations were 
performed using a combination of Microsoft Excel 
(V.2016) and R.28 Given the cross-sectional, point-
prevalence nature of the data set and the fact that the 
study farms are not intended to be a representative 
sample of the population, presented calculations were 
descriptive and no inferences on causality can be made.
Results
Farm demographics
Thirty-four dairy farms were identified as eligible for 
the study through self-nomination or nomination by 
veterinary practices. All were invited to enrol in the 
study, and 29 agreed to take part. Two farms dropped 
out of the study before the medicine inventory visit. 
Data for the remaining 27 farms were complete. These 
farms were located across seven counties and under the 
care of nine veterinary practices.
Farm demographic and management characteristics 
are described in table  1. In summary, the median 
total herd size was 320 with 175 cows in milk. Most 
farms (59 per cent) described the main cattle breed as 
Holstein and the majority calved year-round (81 per 
cent). The median total annual milk volume per herd 
produced was 1.1 million litres, with annual milk sales 
per cow of 7500 litres. Seventy-four per cent of farmers 
had some formal specialised education and training in 
agriculture.
Farm production and health characteristics are 
presented in table 2. Two-thirds of farms used blanket 
dry cow therapy (where all cows were dried off with 
intramammary antimicrobial treatment). Twenty farms 
routinely fed waste milk containing antimicrobial 
residues to beef calves, 13 of which also fed waste 
milk to dairy replacement calves. The mean number of 
clinical cases of mastitis and lameness per 100 cows 
per year was 36.7 and 22.2, respectively. There were a 
median of 10 cases of respiratory disease and 10 cases 
of gastrointestinal disease per 100 calves per year.
Storage methods
Medicines were stored in six different location types 
across the study farms as seen in figure  1. Most were 
stored in a lockable medicine cupboard or refrigerator, 
Table 2 Production, health and medicine storage characteristics of the 27 
participating farms
Property/Characteristics Median or mean*
Range (median) or 
sd (mean)*
Total herd size 320 119–1271
Number of cows in milk 175 65–600
Total annual milk volume (million litres) 1.1 0.5–4
Total annual milk sales per cow (litres) 7500 3600–11 300
Milk price (pence per litre) 22.5* 15.3*
Somatic cell count (cells per millilitre) 176 407* 50 466*
Bactoscan (1000 bacteria per millilitre) 20.9* 7.5*
Mastitis (cases per 100 cows per year) 36.7* 15.9*
Lameness (cases per 100 cows per year) 22.2* 15.3*
Respiratory disease (cases per 100 calves 
per year)
10 0–47
GI disease (cases per 100 calves per year) 10 3–59
Number of PVM present on farm (by active 
ingredient)
19 9–35
Number of PVM present on farm (by medicine 
unit)
101 28–339
* indicates mean; GI, gastrointestinal; median, non-normally distributed data; mean, normally 
distributed data; PVM, prescription veterinary medicines.
Milking parlour
12%
Calf shed
7%
Other unsecure location
10%
Lockable medicine cupboard
Other unsecure location Milking parlourCalf shed
House refrigeratorFarm refrigerator
Lockable medicine
cupboard
63%
Farm refrigerator
6%
House refrigerator
2%
Medicine storage locations
Figure 1 Medicine storage locations across the 27 participating farms. 
Table 3 Total quantities of antimicrobial stored across all 27 participating 
farms, by route of administration
Route of administration Total (mg) Total (medicine units)
All 5 127 176 (100%) 2801 (100%)
Injectable 3 917 116 (76.4%) 280 (10%)
Intramammary 755 772 (14.7%) 2374 (84.8%)
Topical 284 348 (5.5%) 51 (1.8%)
Oral 54 440 (1.1%) 31 (1.1%)
Intrauterine 115 500 (2.3%) 65 (2.3%)
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although 29 per cent were stored in a non-compliant 
area such as the milking parlour, the calf shed or the 
office. Ten farms stored 100 per cent of their medicines in 
lockable medicine cupboards or lockable refrigerators, 
and two farms did not store any medicines in a lockable 
medicine cupboard or lockable refrigerator. No 
participating farm monitored the temperature of their 
refrigerator or medicine storage area.
Prescription veterinary medicines
There were a median of 19 (9–35) different types (by 
active ingredient) of PVM and 101 (28–339) individual 
medicine units of PVM present on participating farms. 
Antimicrobials were the therapeutic group most 
commonly stored both by frequency of occurrence 
(median 69 (22–296) medicine units) and by total 
weight (median 182,300 (45,500–442,500) mg) 
equivalent to 1.54 mg/PCU.
Antimicrobials
The routes of administration for antimicrobials stored 
are presented in table  3. Of the total antimicrobials 
stored across all farms, 76.4 per cent were injectable 
and 14.7 per cent were intramammary. When units 
were measured, 10 per cent were injectable (bottles) 
and 84.8 per cent were intramammary tubes.
Data on antimicrobial storage are presented in 
table 4. The total HP-CIA storage per farm has a median 
of 10,000 mg, or 0.12 mg/PCU, with the majority 
(5000 mg) being third-generation cephalosporin. 
Injectable antimicrobials comprised the greatest total 
weight, with a median of 143,600 mg or 1.19 mg/PCU, 
compared with intramammary antimicrobials which 
had a median of 21,200 mg or 0.21 mg/PCU. Conversely, 
intramammary antimicrobials had the greatest total 
number of medicine units present, with a median 
of 66 units compared with nine units of injectable 
antimicrobials.
Eighty-nine per cent of farms stored at least one 
HP-CIA. The most frequently occurring injectable 
antimicrobials were ceftiofur (HP-CIA; n=24) and 
penicillin/streptomycin combination (n=24). Also 
commonly found were oxytetracycline (n=22), tylosin 
(n=19) and trimethoprim/sulphadiazine (n=16). The 
three lactating-cow intramammary antimicrobials 
most commonly identified were potentiated amoxicillin 
(n=11), the combination streptomycin/neomycin/
novobiocin/penicillin (n=11) and cefalexin/kanamycin 
(n=10). The most frequently occurring dry cow 
intramammary antimicrobials were cephalonium 
(n=12), cefquinome (HP-CIA; n=10) and cloxacillin 
(n=8).
The total milligram per PCU on each farm ranged 
from 0.51 to 5.08 mg/PCU (figure 2). The total milligram 
per cow in milk ranged from 430 to 3430 mg (figure 3). 
The total milligram per 1000 litres of milk produced 
annually ranged from 40 to 740 mg (figure 4).
Vaccines and other PVM
The total number of vaccine doses stored across all 
farms was 3541 with a median of 0 (0–1893) dose per 
farm. Eighteen farms (66.7 per cent) stored no vaccines 
at the time of the study. The most common diseases for 
which vaccines were stored were bovine herpesvirus 
1 (866 doses; five farms), leptospirosis (835 doses; 
five farms) and bovine viral diarrhoea (683 doses; five 
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Figure 2 Total quantity of antimicrobial stored on each participating farm 
(n=27) in mg/PCU. HP-CIA, highest priority critically important antimicrobial; PCU, 
population corrected unit. 
Table 4 Quantity of antimicrobial stored on the 27 participating farms
Antimicrobial type
Total Total Total
Farms where
present (n)
(mg) (mg/PCU) (medicine units)
Median Range Median Range Median Range
Total antimicrobial 182 200 45 500–442 400 1.54 0.51–5.08 69 22–296 27
Total HP-CIA 10 000 0–68 000 0.12 0.00–0.34 5 0–95 24
Fluoroquinolone 0 0–32 000 0 0.00–0.19 0 0–4 11
Third-generation cephalosporin 5000 0–36 000 0.06 0.00–0.30 1 0–5 19
Fourth-generation cephalosporin 1000 0–9000 0.01 0.00–0.12 0 0–59 13
Injectable (all) 143 600 16 500–393 000 1.19 0.19–4.51 9 1–35 27
Intramammary (all) 21 200 1000–111 400 0.21 0.01–0.49 66 5–248 27
Other (all) 13 200 0–61 800 0.11 0.00–0.63 5 0–24 21
Injectable (HP-CIA) 5000 0–36 000 0.09 0.00–0.34 2 0–6 24
Intramammary (HP-CIA) 1000 0–9000 0.01 0.00–0.12 0 0–93 12
Other (HP-CIA) 0 0 0 0 0 0 0
HP-CIA, highest priority, critically important antimicrobial (ref: European Medicines Agency); PCU, population corrected unit.
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farms). Other diseases for which vaccines were stored 
were calf diarrhoea, bluetongue, clostridial diseases, 
lungworm, mastitis and calf pneumonia.
The total number of units of NSAIDs across all farms 
was 75, with a median of 2 per farm (0–8). The total 
number of anthelmintics or antiprotozoals present 
across all farms was 87, also with a median of 2 per farm 
(0–14). The total number of units of hormone across all 
farms was 53, with a median of 1 (0–10) unit per farm. 
Five farms (19 per cent) stored prostaglandins.
Expired medicines
At least one unit of expired PVM was stored on 25 farms 
(93 per cent). Eighteen farms (67 per cent) stored at 
least one expired antimicrobial and six (22 per cent) 
stored at least one expired vaccine. The total number 
of expired antimicrobial units across all farms was 201, 
with each farm storing a median of 2 (0–58) expired 
antimicrobials. The total number of doses of expired 
vaccines stored across all farms was 827, with each 
farm storing a median of 0 (0–725) expired dose.
The median length of time since expiration was 12 
(1–200) months. For antimicrobials, the median length 
of time since expiration was 10 (1–96) months, for 
anti-inflammatories 6 (2–42) months, for vaccines 20 
(2–200) and for other medicines 12 (2–120) months, 
with the majority of the ‘other’ medicines endectocides.
Cascade medicines
Medicines not licensed for use in dairy cattle were found 
on 16 farms (59 per cent). A total of 30 unlicensed 
units were stored, comprising 14 different medicines. 
Seven different unlicensed antimicrobials were 
identified totalling 709,100 mg of active ingredient. 
Macrolides were the most common, with 138,600 mg of 
erythromycin (licensed for use in poultry and pigs) found 
across seven farms served by two different veterinary 
practices—2000 mg lincomycin on one farm (licensed 
for use in pigs) and 200 mg gentamicin (licensed for 
use in horses not producing milk or meat for human 
consumption) on one farm. Also found were 500,000 mg 
of tetracyclines (licensed for use in poultry and pigs) 
across three farms served by one veterinary practice, 
5000 mg metronidazole veterinary tablets (licensed for 
use in dogs and cats but banned from use in cattle) on 
one farm, 18,000 mg of first-generation cephalosporin 
of Hungarian origin and not licensed for sale in the 
UK on one farm, and 30,000 mg of florfenicol of Dutch 
origin not licensed for sale in the UK on a different 
farm. There was no clustering of unlicensed products by 
farm. Other unlicensed medicines identified were 50 ml 
of mepivacaine (a local anaesthetic agent licensed for 
use in horses), 1 tube of acepromazine gel and 30-ml 
romifidine (sedatives licensed for use in horses), 
2 capsules of 2-mg loperamide (an antispasmodic 
licensed for human use), 200-ml sucralfate, 2 tubes of 
fusidic acid gel (an antibiotic topical gel licensed for use 
in cats and dogs) and one bottle of topical miconazole 
licensed for use in dogs. Where unlicensed medicines 
were found, farmers confirmed they were present for 
use in the dairy calves or adult cattle.
Discussion
Most farms in this study stored PVM in the recommended 
way. However, some PVMs were being stored in 
inappropriate conditions, for example, in areas at risk 
from heat or cold damage and exposure to sunlight or 
gross contamination. Twenty-nine per cent of PVM found 
were not stored in a lockable cupboard or room. This 
has direct health and safety implications due to access 
to potentially harmful medicines by animals or children 
in addition to risks of theft. Certain medicines should 
be stored with particular care due to their potential for 
harm from accidental exposure.18 Prostaglandins, for 
example, which made up a proportion of the hormone 
POM-V reported in the Results section, can be absorbed 
transcutaneously and lead to miscarriage or serious 
and even fatal respiratory compromise in susceptible 
people.30
While some farms stored a wide range of different 
types and quantities of PVM, others stored a limited 
number. The fact that the quantity of antimicrobials 
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milligrams per 1000 litres of milk produced annually. HP-CIA, highest priority, 
critically important antimicrobial. 
 o
n
 11 January 2019 by guest. Protected by copyright.
http://veterinaryrecord.bmj.com/
Veterinary Record: first published as 10.1136/vr.105041 on 9 Novem
ber 2018. Downloaded from
 
 | Vet RecoRD6
stored on farm does not appear to be linked with the 
number of animals at risk of treatment or the overall 
production values of the cows on the farm (figures 2–4) 
suggests that there are other reasons for the range of 
storage practices seen. Ongoing work by the lead author, 
as part of a wider study, is exploring these reasons.31
As previously noted, a farmer’s treatment decisions 
are to some extent constrained by the PVM resources 
available to them. It follows therefore that when 
designing policy interventions aimed at reducing AMU, 
data on storage practices and farmers’ use of stored 
medicines are extremely important.
Antimicrobial storage
Antimicrobials were the PVM stored in the greatest 
quantity when measured by total milligram of active 
ingredient as well as by individual medicine units. 
Twenty-four farms stored HP-CIAs, indicating that 
their use is still common in UK dairy farming; however, 
recent increased efforts to reduce their use mean this 
is likely to be a rapidly evolving picture. For example, 
as of June 2018 the Red Tractor Farm Assurance will 
require HP-CIAs only be used as a last resort, with a 
veterinary report outlining diagnostic or sensitivity 
testing.32 While storage does not equate to actual use, 
it is likely that these antimicrobials are stored with the 
intention of use, and therefore it may be that the use 
of HP-CIAs was still common practice during the period 
of the study. Data from the wider longitudinal research 
study are in preparation for publication and will report 
on actual PVM use on these farms including HP-CIA use 
over a 12-month period.
The number of bottles of injectable antimicrobial 
present on farms was as high as 35 on one farm, with 
a median of 9. Keeping a store of antimicrobials like 
this provides a large resource for the farmer to use 
without a need to consult her/his veterinarian. One 
of the most frequently kept injectable antimicrobials 
was ceftiofur, an HP-CIA. Given the focus on reducing 
the use of HP-CIAs in the years preceding the study, 
this may be indicative of a reluctance to move away 
from their use in the dairy sector. The 0-hour milk 
withhold carried by ceftiofur and its broad licensing 
for use in respiratory disease, metritis and interdigital 
necrobacillosis made it an attractive and cost-effective 
option for treating disease on farm, and it appears to 
have remained popular at least until the latter part of 
2016. The antimicrobials most commonly used for 
treating mastitis in the lactation period were not on the 
current HP-CIA list, although potentiated amoxicillin 
is not considered to be a first-line treatment.33 The 
most commonly stored antimicrobials for treating 
dry cows included cefquinome, a fourth-generation 
cephalosporin and HP-CIA.
Many of the first-line, ‘responsible’ antimicrobials 
have a relatively high total weight of active ingredient 
when compared with HP-CIAs, leading to calls for 
HP-CIAs to be measured and benchmarked separately 
from other antimicrobials.6 7 This study provides 
evidence that there is an ongoing need to change 
behaviour and reduce the use of HP-CIAs on dairy farms.
Interestingly, when measured in mg/PCU or 
mg/1000-litre milk produced annually, the data show 
that while most farms stored similar quantities of 
antimicrobial, a handful of farms stored up to 10 times 
as much as those farms which stored the smallest 
amounts. This suggests other factors affect the storage 
practices of dairy farmers, something being investigated 
in ongoing work by the authors.
Participating farms stored a broad range of different 
antimicrobials, thus increasing their options when 
making treatment decisions. This could lead to a 
dissonance between the intention of the prescribing 
veterinarian and the actions of the farmer. Having 
such a large resource to draw upon could be seen to 
improve the agency and ownership of the farmer on 
those decisions, but conversely to decrease the agency 
and ownership of the veterinarian legally responsible 
for their use. This serves to emphasise the importance 
of understanding the treatment decisions, given the 
relatively few resource constraints.
Expired medicines
While the presence of expired medicines does not equate 
to their use, the fact that expired PVMs were identified 
on most participating farms indicates that their use is 
likely to be common. Expiry dates for drug products are 
set based on real-time stability testing at appropriate 
storage conditions to determine whether the drug 
substance meets its individually set specification.34 A 
specification ‘establishes the set of criteria to which 
a drug product should conform to be acceptable for 
its intended use’.35 All but two farms stored at least 
one expired PVM, with two-thirds storing at least one 
expired antimicrobial. This is particularly striking when 
compared with studies of household medicine storage 
among human health, which have shown a range of 
3–22 per cent of stored medicines were expired.36 37 
Given the average length of time passed since expiry 
was 12 months, with one farm storing medicine that 
was over 16 years out-of-date, their presence appears to 
be accepted by farmers on dairy farms.
The impact of using an expired antimicrobial 
is ill-defined. It is assumed that the efficacy of an 
antimicrobial, or indeed any medicine, reduces with 
time after expiration. However, the evidence base for 
this is small and contradictory. In one study from human 
health, it was shown that there was a decreased rate 
of pathogen susceptibility to expired antimicrobials.38 
Other studies have shown that most medicines retain 
their efficacy for many years beyond their expiration 
date.39 40 To the authors’ knowledge, there are no studies 
on the efficacy of expired antimicrobials in veterinary 
medicine.
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Perhaps more important than the expiry date stated 
on PVM is the shelf-life of the medicine once broached. 
In-use shelf-life is determined for multiuse veterinary 
products by in-use stability testing of physical, chemical 
and microbial properties. Products approaching the 
end of their shelf-life are tested, with testing designed to 
simulate as closely as possible real-life conditions based 
on likely usage patterns of the product under ‘normal 
environmental conditions’ and stored according to 
the product literature. These drugs are measured 
against either their original specification or an ‘in-use 
shelf life’ specification, as appropriate.41 While this is 
often 28 days for injectable products and 24 hours for 
vaccines, in reality these shelf-lives are rarely observed 
due to most injectable medicines being sold in 100-ml 
or 250-ml multidose bottles, and individual animals’ 
treatment courses require varying volumes of medicine. 
Measuring the presence and use of PVM that had 
passed its broached shelf-life was beyond the scope of 
this study; however, future research in this area would 
be valuable.
Expired or waste PVM should not be disposed of with 
normal household waste, and most veterinary practices 
offer a disposal service to clients. Given the prevalence 
of expired PVM on the study farms, veterinarians 
should determine whether the farms under their care 
are disposing of these medicines appropriately or 
whether they remain on farm with potential for use. 
Discussion of the use and disposal of expired PVM 
would make a valuable addition to herd health review 
meetings, particularly given the veterinarian’s ultimate 
responsibility for the safety of medicines being used in 
these food-producing animals.
The Cascade
Using PVMs which are not licensed for use in dairy cattle 
is not illegal if they are prescribed and used according to 
the Cascade and where there are established maximum 
residue limits.42 However, the use of unlicensed PVM is 
not currently monitored in the UK. Given the presence of 
medicines which have been prescribed via the Cascade, 
further research is urgently needed in this area. In 
one instance, PVMs were present which are explicitly 
banned from use in dairy cattle (metronidazole): 
administration would constitute a transgression of the 
law.43
Study limitations
The use of purposive sampling through veterinary 
practice nomination inevitably leads to the possibility 
of selection bias. The study farms were demographically 
reflective of the wider UK dairy farm population. 
According to the Agriculture and Horticulture 
Development Board (AHDB) the ‘average number of 
adult dairy cows’ on UK dairy farms in 2016 was 143,44 
compared with the study farm median of 175. The larger 
herd size of the study farms may influence the way in 
which PVMs are stored. Larger herds are more likely to 
have an increased frequency of veterinary visits, which 
may mean they store fewer PVMs on the farm as they 
have additional resources available to them through the 
veterinarian on a regular basis.
Farmers were asked not to alter the medicines stored 
on their farms for the visit day. Given the prevalence of 
expired medicines and storage of medicines outside of 
designated cupboards, it appears that farmers did not 
significantly improve their storage practices before the 
visit, and the authors believe the data described are 
representative of normal medicine storage on the study 
farms. The volume of medicines in opened bottles was 
estimated by eye to the nearest 10 ml, which may have 
led to some overestimation or underestimation of the 
total volume present on farm. Using reference weights 
for different medicines and a portable weighing scale to 
measure the weight of bottles may have improved the 
accuracy of these measurements.
This study was cross-sectional, and the seasonal 
nature of dairy farming and disease prevalence 
should be noted. This study took place in the Autumn, 
around the time of housing for many farms, and 
the data may be different if it was to be repeated in 
different seasons. Where mixed-enterprise farms were 
included, these stored medicines intended for use 
in dairy cattle and calves separately from medicines 
intended for beef or sheep. This did not allow for any 
measurement of the possibility of medicines stored for 
use in beef and sheep being used in the dairy cattle. 
It is also important to note that this study reports 
storage practices on a small number of dairy farms 
in South West England and South Wales, and as such 
may not reflect practices found on other farms or in 
other regions of the UK. Further research in this area 
is needed to provide a robust evidence base for future 
policy decisions aimed at improving responsible 
medicine use in dairy farming.
Conclusions
These are the first data of their kind published on 
the UK situation and are useful to help veterinarians 
understand the ways in which medicines are being 
used postprescription and to inform future herd health 
planning. Current UK estimates of PVM use are crude 
and only through detailed on-site research can real 
medicine use practices be discerned. The results are also 
helpful for policy makers and researchers to broaden 
the evidence base surrounding PVM use.
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